Skip to main content
Premium Trial:

Request an Annual Quote

OneOme's RightMed Test

OneOme has launched its RightMed test, a 22-gene pharmacogenomic assay intended to be provided as part of routine clinical care. The company said the test can potentially inform treatment decisions across more than 340 medications. OneOme has also developed a platform that allows users to generate a report to guide prescribing using genotype or sequence data obtained elsewhere.

RightMed will be offered through the company's CLIA-registered laboratory in Minneapolis, which it opened in July. OneOme has also entered the market in Puerto Rico, Cuba, and the Dominican Republic through a partnership with High Profile Laboratory in Guaynabo, Puerto Rico. 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.